Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor
(EGFR) gene in lung cancers have generated enormous interest, because they predict for …

… expression of vascular endothelial growth factor (VEGF) were investigated in 108 cases of
NSCLC by immunohistochemistry. The correlation between von Willebrand factor (vWf) and …

… lung cancers have aberrant production of multiple growth factors and aberrant expression
of multiple growth factor receptors.1, 2 The non–small cell lung cancers (NSCLCs) frequently …

… andcoagulation-fibrinolysis factors in patients with advanced lung cancer, the association of
… lung cancer. The measurement of serum VEGFlevels may be useful to evaluate lung cancer …

… The role that growth factors and their receptors play in human cancer growth and … Our
approach consisted of active immunotherapy with the epidermal growth factor (EGF). Two pilot …

… growth factor (VEGF), also known as vascular permeability factor, in the recurrence of lung
… that VEGF may play an important role in the rapid growth of dormant lung micrometastases. …

… Clinical and biological features associated with epidermal growth factor receptor gene
mutations in lung cancers. J Natl Cancer Inst 2005; 97: 339-346, doi: 10.1093/jnci/dji055. …

Introduction Human epidermal growth factor receptor 2 (HER2) is regarded as a poor
prognostic factor in many tumors. Conflicting data in many literatures were reported about the …

… Lung cancer is the leading cause of cancer-related deaths worldwide, … the USA, lung cancer
accounts for approximately 28% of all cancer-related deaths [2]. Non-small cell lung cancer (…

… Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide. …
-targeted agents including the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-…